Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
Scope of the Report:
The global average gross margin of specialty drug distribution is in the decreasing trend, from 7.85% in 2011 to5.97% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of specialty drugs includes oncology, rheumatoid arthritis, multiple sclerosis, hemophilia and others. The proportion of oncology drugs in 2015 is about 45.8%, and the proportion of rheumatoid arthritis drug in 2015 is about 15.4%.
Specialty drugs are widely sold by retail, home health, clinics, and pharmacies. The most proportion of specialty drugs are sold by clinics and the market share in 2015 is about 37.6%.
North America region is the largest supplier of specialty drug distribution, with a sales revenue market share nearly 45.6% in 2015. Europe is the second largest supplier of specialty drug distribution, enjoying sales revenue market share about 31.7% in 2015.
Market competition is intense between the giant, Amerisource, Mckesson, Cardinal Health, etc. are the leaders of the industry in North America, PHOENIX, Alliance Healthcare, Celesio, etc. are the leaders of the industry in Europe and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Specialty Drug Distribution market is valued at 640 million USD in 2018 and is expected to reach 1270 million USD by the end of 2024, growing at a CAGR of 12.0% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Specialty Drug Distribution.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Specialty Drug Distribution market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Specialty Drug Distribution market by product type and applications/end industries.
Market Segment by Companies, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into